Lexaria Bioscience Corp., 2025-12-19
An SEC Form D private-offering notice from Kelowna, BC, Canada, a $3,500,004 filer-stated offering target in Biotech. Filed 2025-12-19. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotechnology company developing DehydraTECH, a drug delivery technology that improves bioavailability of active pharmaceutical ingredients.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Amphix Bio, Inc., 2025-12-19, $12.5M, Chicago, IL
- Avana Health, Inc., 2025-12-19, $4M, Lexington, KY
- Phylos Bioscience, Inc., 2025-12-19, Portland, OR
- NEONC TECHNOLOGIES HOLDINGS, INC., 2025-12-18, $1M, Calabasas, CA
- Ceretype Neuromedicine, Inc., 2025-12-18, $400K, Cambridge, MA
- InSitu Biologics, Inc, 2025-12-18, $8M, Oakdale, MN
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.